After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $34.16B. A total of 9.29 million shares were traded on the day, compared to an average of 11.32M shares.
In the most recent transaction, Bridger Management, LLC (1) bought 150,000 shares of TEVA for 30.18 per share on Dec 12 ’25. In a previous transaction on Dec 09 ’25, Daniell Richard sold 115,468 shares at 28.68 per share. TEVA shares that Exec. VP, European Commercial owns now total 48,384.
Among the insiders who sold shares, Sabag Mark disposed of 216,892 shares on Dec 09 ’25 at a per-share price of $28.73. This resulted in the See “Remarks” holding 52,828 shares of TEVA after the transaction. In another insider transaction, Sabag Mark bought 216,892 shares at $28.73 per share on Dec 09 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TEVA has a high of $30.20 and a low of $12.47.
As of this writing, TEVA has an earnings estimate of $0.66 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.78 per share and a lower estimate of $0.58. The company reported an EPS of $0.71 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $6.32, while its Total Shareholder’s Equity was $11.24B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.83.
